Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

Suppr

超能文献

作者信息

Neugebauer G

出版信息

Cardiovasc Res. 1978 Apr;12(4):247-54. doi: 10.1093/cvr/12.4.247.

DOI:10.1093/cvr/12.4.247

PMID:657182

Abstract

摘要

相似文献

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.

Cardiovasc Res. 1978 Apr;12(4):247-54. doi: 10.1093/cvr/12.4.247.

[Cardiovascular effects of the slow intravenous infusion of verapamil].

Arq Bras Cardiol. 1982 Feb;38(2):111-4.

Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.

Am J Cardiol. 1982 Oct;50(4):886-93. doi: 10.1016/0002-9149(82)91250-4.

Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog.

J Cardiovasc Pharmacol. 1980;2(3):309-18. doi: 10.1097/00005344-198005000-00008.

Effects of nifedipine on coronary and systemic hemodynamics in the conscious dog.

Arzneimittelforschung. 1979;29(9):1361-8.

[Cardiovascular effects of dimethophrine in the dog].

G Ital Cardiol. 1973;3(1):102-11.

Inhibition of myocardial reactive hyperaemia but not of hypoxic coronary vasodilatation by constant verapamil infusion in the in situ dog heart.

Acta Physiol Acad Sci Hung. 1982;59(2):187-95.

Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic serum concentration: an effect blocked by verapamil.

J Pharmacol Exp Ther. 1991 Apr;257(1):214-8.

Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552).

Mater Med Pol. 1985 Apr-Jun;17(2):103-6.

Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.

Circ Res. 1983 Feb;52(2 Pt 2):I29-39.

引用本文的文献

A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.

Clin Pharmacol Ther. 2024 Feb;115(2):324-332. doi: 10.1002/cpt.3108. Epub 2023 Dec 11.

The human proton pump inhibitors inhibit rifampicin efflux and macrophage-induced rifampicin tolerance.

Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2215512120. doi: 10.1073/pnas.2215512120. Epub 2023 Feb 10.

Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.

Biochem Pharmacol. 2016 Oct 15;118:96-108. doi: 10.1016/j.bcp.2016.08.013. Epub 2016 Aug 13.

Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.

Biosci Rep. 2016 Jan 28;36(2):e00309. doi: 10.1042/BSR20150317.

Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.

J Infect Dis. 2014 Aug 1;210(3):456-66. doi: 10.1093/infdis/jiu095. Epub 2014 Feb 14.

Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Br J Clin Pharmacol. 2011 Nov;72(5):787-97. doi: 10.1111/j.1365-2125.2011.04019.x.

Effect of levosimendan in experimental verapamil-induced myocardial depression.

Scand J Trauma Resusc Emerg Med. 2010 Mar 11;18:12. doi: 10.1186/1757-7241-18-12.

Transformation of verapamil by Cunninghamella blakesleeana.

Appl Environ Microbiol. 2004 May;70(5):2722-7. doi: 10.1128/AEM.70.5.2722-2727.2004.

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

Br J Cancer. 1998 Apr;77(7):1155-63. doi: 10.1038/bjc.1998.192.

R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.

Br J Clin Pharmacol. 1993 Aug;36(2):93-8. doi: 10.1111/j.1365-2125.1993.tb04202.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验